- Research works
- 10 ▼ 18% vs 2018-21
- Citations
- 215 21.9 per fractional work
- Top-10% rate
- 3.6% all institutions 10.0%
- Open access
- 28% world 40%
- International
- 15% world 18%
Not ranked overall: PhaseBio Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does PhaseBio Pharmaceuticals (United States) work in?
In all years, 64% of research at PhaseBio Pharmaceuticals (United States) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (64%), Biochemistry, Genetics and Molecular Biology (22%), Neuroscience (9%). It does 1.8× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 7 fields, with their numbers
- Health Sciences664.3%
- Medicine664.3%
- Life Sciences331.9%
- Social Sciences03.0%
- Physical Sciences00.8%
- Chemistry00.8%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at PhaseBio Pharmaceuticals (United States)?
Ranked on the quality score, Sue Arnold lead among researchers whose main affiliation is PhaseBio Pharmaceuticals (United States).
- 1
Sue Arnold
United States · #4,213,982 worldwide 156 citations · 23 works
Which research topics does PhaseBio Pharmaceuticals (United States) publish most on?
By volume in 2022-now: Hormonal Regulation and Hypertension, Steroid Chemistry and Biochemistry, Antiplatelet Therapy and Cardiovascular Diseases and Coronary Interventions and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 1 works
- 2 Steroid Chemistry and Biochemistry Molecular Biology 0 works
- 3 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 0 works
- 4 Coronary Interventions and Diagnostics Surgery 0 works
- 5 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
- 6 Platelet Disorders and Treatments Hematology 0 works
- 7 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 8 Lipoproteins and Cardiovascular Health Surgery 0 works
- 9 Adrenal Hormones and Disorders Endocrinology, Diabetes and Metabolism 0 works
- 10 Electrolyte and hormonal disorders Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has PhaseBio Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 18% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is PhaseBio Pharmaceuticals (United States) as a percentage of every work published that year, 0.000027% in 2022.
Fractional works of PhaseBio Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Malvern
- Siemens Healthcare (United States)
- Endo Pharmaceuticals (United States)
- Immaculata University
- Ricoh (United States)
- Reaction Biology Corporation (United States)
- Applied Pulsed Power (United States)
- TetraLogic Pharmaceuticals (United States)
- Saint-Gobain (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about PhaseBio Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.